ESTRO 2024 - Abstract Book

S2364

Clinical - Urology

ESTRO 2024

Conclusion:

To our knowledge, this is the first clinical outcome report of Hypo-MRgSRT in post-prostatectomy patients. Hypo MRgSRT was feasible, safe, and well tolerated by patients. The encouraging low toxicity profile and preliminary outcome warrant further validation in clinical trials.

Keywords: MR-guided radiotherapy, prostate bed